Source comparison
Rotate CJC-1295 No DAC Injection Sites — Comparison
4-zone (abdomen only) 96 hours (minimum) Moderate. Acceptable for 4–6 week protocols only Low. Easy to remember without tracking Short-term studies under 6 weeks; researchers with limited injection experience Acceptable as a starting protocol but insufficient
This comparison does not assign a generated winner or score.
- 4-zone (abdomen only)
- 96 hours (minimum)
- Moderate. Acceptable for 4–6 week protocols only
- Low. Easy to remember without tracking
- Short-term studies under 6 weeks; researchers with limited injection experience
- Acceptable as a starting protocol but insufficient for studies exceeding six weeks. Tissue fatigue becomes inevitable beyond this timeframe
- 8-zone (abdomen + hips + thighs)
- 7 days
- Low. Suitable for 8–12 week protocols
- Moderate. Requires tracking system after week two
- Standard twice-daily CJC-1295 protocols; researchers seeking maximum tissue preservation
- Gold standard for daily administration. Provides adequate recovery without unnecessary complexity
- 12-zone (full rotation including posterior sites)
- 10–12 days
- Very low. Prevents tissue fatigue indefinitely
- High. Mandatory tracking and occasional assistance for posterior sites
- Extended protocols beyond 12 weeks; researchers with prior lipohypertrophy
- Overkill for most protocols but essential for anyone with existing scar tissue or long-duration studies
- Random site selection (no pattern)
- Variable. Often <48 hours between same-site use
- High. Nodules develop within 3–4 weeks
- None (chaotic)
- No one. This is a protocol failure waiting to happen
- The most common mistake we see. Visual memory fails and researchers unconsciously favor 2–3 sites, creating localized tissue damage that could have been entirely prevented